GlaxoSmithKline doubles down on Vir pact, throwing in $345M upfront to go beyond COVID-19
Last year, Big Pharma GlaxoSmithKline and George Scangos’ biotech Vir joined forces against COVID-19. Now, the pair is turning its...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
Feb 11, 2021
Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company
Combined company renamed Nuvation Bio Inc., will be listed on the New York Stock Exchange under ticker symbol "NUVB" Strong cash position...
Feb 4, 2021
Sana snags $587.5M IPO to catapult cell therapies into the clinic
Massive private raise? Check. Preclinical pipeline? Check. Now, Sana Biotechnology is raising $587.5 million in a mammoth IPO that will...
Feb 1, 2021
Gilead Sciences and Gritstone Announce Collaboration For HIV Cure
FOSTER CITY, Calif. and EMERYVILLE, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) and Gritstone...
bottom of page